Продукты

1010 Expert Conversations

    1010 Expert Conversations
    Most patients with fatty liver disease & NASH do not have symptoms. Alcohol is often not to blame. 17
    $0
    МРТ печени. МРХПГ поджелудочной железы. МРХПГ или ЭРХПГ? 9
    $0
    Multiple myeloma and bone marrow microenvironment. ‘Seed and soil’ concept in cancer progression. 3
    $0
    Multiple myeloma and gene expression profiling. Intraclonal heterogeneity. 4
    $0
    Multiple myeloma. FAQ: Immunization, Vitamin D and bone health, quality of life. 12
    $0
    Multiple myeloma. Genetic changes. MGUS. Smoldering myeloma. 2
    $0
    Multiple myeloma. Message of hope for cancer treatment and for life. 14
    $0
    Multiple myeloma. Minimal Residual Disease evaluation. Prognosis. 9
    $0
    Multiple myeloma. Patient’s story: elderly woman and ‘last hope’ CAR T-cell therapy. 13
    $0
    Multiple myeloma. Progress and challenges of treatment. 1
    $0
    Multiple myeloma. Risk stratification criteria to select the best treatment for each patient. 5
    $0
    Генетические факторы риска рассеянного склероза. 4
    $0
    Рассеянный склероз. Как потеря нейронов влияет на прогноз. 1
    $0
    Multisystem inflammatory syndrome in children. MIS-C. Kawasaki disease. 1
    $0
    Multisystem inflammatory syndrome in children. MIS-C. Prognosis and recovery. 3
    $0
    Multisystem inflammatory syndrome in children. MIS-C. Susceptibility factors. 2
    $0
    Миелодиспластический синдром. Лечение и прогноз. 3
    $0
    Миелопролиферативное заболевание. Диагностика и лечение. 4
    $0
    Натуральная терапия жировой болезни печени. 4
    $0
    Recently viewed Expert Conversations